叶黄素
医学
伊立替康
吉西他滨
奥沙利铂
胰腺癌
肿瘤科
氟尿嘧啶
内科学
养生
化疗
癌症
结直肠癌
作者
Thierry Lecomte,François Ghiringhelli,Marc Ychou,Olivier Bouché,Rosine Guimbaud,Yves Bécouarn,Antoine Adenis,Jean‐Luc Raoul,S. Gourgou-Bourgade,Jaafar Bennouna,Jean–Baptiste Bachet,Jean–Baptiste Bachet,Faiza Khemissa-Akouz,Denis Péré-Vergé,Catherine Delbaldo,Éric Assenat,Jean‐Yves Blay,Pierre Michel,C. Montoto-Grillot,Michel Ducreux
标识
DOI:10.1056/nejmoa1011923
摘要
Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI